What's breaking now, across thousands of outlets.
Roche is back with more data Tuesday for the lead drug it obtained from Carmot Therapeutics — this time from a mid-stage trial in overweight or obese people with type 2 diabetes. The Swiss drugmaker’s enicepatide ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The government of the Region of Murcia is funding nearly 400 day centre places for people living with Alzheimer’s. The […]
A record number of people have been infected with the tick-borne viral disease TBE in Sweden this year.
The failed samples during routine regulatory surveillance included 29 tested by the Central Drugs Laboratories
The government has announced “most-favored-nation” pricing agreements with 26 pharma companies. But the deals could stymie other plans to lower the country’s spending on prescription drugs.
Children as young as 8 in the US are being prescribed off-label GLP-1 weight-loss drugs, sparking debate about the potential long-term health effects
More than one in five U.S. adults lives with chronic pain, which isolation and stigma can worsen. Group medical visits allow multiple patients with a common condition to receive care alongside health…
